ArticleClinical, cosmetic and investigational dermatology2022

Recalcitrant Ulcerative Pyoderma Gangrenosum of the Leg Responsive to Tildrakizumab: A Case Report.

Liang Joo Leow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.